medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2013, Number 607

<< Back Next >>

Rev Med Cos Cen 2013; 70 (607)

Síndrome de intestino irritable

Ramírez S, Villanueva A

Language: Spanish
References: 10
Page: 511-514
PDF size: 702.53 Kb.


ABSTRACT

Irritable bowel syndrome is characterized by chronic abdominal symptoms and irregular bowel movements, which there is no known structural or anatomical explanation. Such symptoms, like abdominal pain, bloating and bowel pattern abnormalities compromise patients daily functioning. In recent years its pathophysiology has come to be much better understood, and has been related to abnormal motility, visceral hypersensibility, dysfunctional gut-brain axis, and psychosocial abnormalities. New therapeutic approaches have been developed to treat these patients, depending on the predominance of the symptoms.


REFERENCES

  1. Andresen V, Keller J, Pehl C, Schemann M, Preiss J, Layer P. Irritable Bowel Syndrome- The main recommendatios. Dtsch Arztebl Int 2011; 108(44); 751- 760.

  2. Faroup PG, Jacobsen M, Ligaarden SC, Rudi K. Probiotics, Symptoms, and Gut Microbiota: what are the relations? A randomized controlled trial in subjects with irritable bowel syndrome. Gastroenterology Research and Practice. 2012; 1-6

  3. Keszthelyi D et al. Increased proton pump inhibitor and NSAID exposure in irritable bowel syndrome: results from a case control study. BMC Gastroenterology 2012, 12:121

  4. Martinez C, Gonzalez A, Vicario M, Santos J. Cellular and Molecular basis of intestinal barrier dysfunction in the irritable bowel síndrome. Gut and Liver 2012; 6: 305-315.

  5. McPhee SJ, Papadakis MA. Current Medical Diagnosis and Treatment. McGraw Hill, 2012. Pag 614-618.

  6. Olden KW. Targeted therapies for diarrhea-predominant irritable bowel syndrome. Clinical and experimental Gastroenterology 2012; 5:69-100.

  7. Sinagra E, Romano C, Cottone M. Psychopharmacological treatment and Psychological Intervention in Irritable Bowel Syndrome. Gastroenterology Research and Practice 2012; 1-11

  8. Spiller R, Lan C. An update on Post- Infectious Irritable Bowel Syndrome: role of genetics, immune activation, serotonin and altered microbiome. J Neurogastroenterol Motil. 2012; 18(3): 258-268.

  9. Wang TY, Lim HY, Tai D, et al. The impact of irritable bowel syndrome on health- related quality of life: a Singapore perspective. BMC Gastroenterology 2012; 12: 104.

  10. Yale SH et al. Applying case definition criteria to irritable bowel syndrome. Clinical Medicine and Research. 2008; 6(1): 9-16.




2020     |     www.medigraphic.com